REGULATORY INTELLIGENCE·Recall
Sun Pharma's XELPROS Recall: Particulate Matter Prompts Supply Chain Review for Latanoprost
Sun Pharmaceutical Industries, Inc. has initiated a voluntary Class III recall of 35,069 bottles of XELPROS (latanoprost ophthalmic emulsion) 0.005% due to out-of-specification particulate matter. This event, impacting distribution in Texas and Pennsylvania, necessitates immediate action from procurement and regulatory teams to assess supply chain vulnerabilities and ensure patient safety for this critical glaucoma medication.
90-Day Activity